Drug Shortage Report for MINT-PIOGLITAZONE
| Report ID | 95924 |
| Drug Identification Number | 02326485 |
| Brand name | MINT-PIOGLITAZONE |
| Common or Proper name | Pioglitazone |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PIOGLITAZONE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 count bottles |
| ATC code | A10BG |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-09 |
| Estimated end date | 2021-12-31 |
| Actual end date | 2022-03-03 |
| Shortage status | Resolved |
| Updated date | 2023-01-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-10-09 | English | Compare |
| v2 | 2019-10-09 | French | Compare |
| v3 | 2019-10-10 | English | Compare |
| v4 | 2020-01-27 | English | Compare |
| v5 | 2020-01-27 | French | Compare |
| v6 | 2020-04-09 | English | Compare |
| v7 | 2020-04-09 | French | Compare |
| v8 | 2020-04-25 | English | Compare |
| v9 | 2020-04-25 | French | Compare |
| v10 | 2021-08-13 | English | Compare |
| v11 | 2021-08-13 | French | Compare |
| v12 | 2023-01-03 | English | Compare |
| v13 | 2023-01-03 | French | Compare |
Showing 1 to 13 of 13